These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 6171833)
1. The immune system in gynecologic malignancies. Barber HR; Dorsett B Prog Clin Biol Res; 1981; 70():357-69. PubMed ID: 6171833 [No Abstract] [Full Text] [Related]
2. Tumour markers in ovarian cancer. van Nagell JR Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919 [No Abstract] [Full Text] [Related]
3. The value of tumor markers in cancer of the ovary. Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620 [No Abstract] [Full Text] [Related]
4. Biological markers in gynecologic cancers. An overview. Dini MM; Miller M IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177 [No Abstract] [Full Text] [Related]
5. [Significance of tumor markers in clinical oncology]. Gericke D; Drahovsky D Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005 [No Abstract] [Full Text] [Related]
6. Immunodiagnosis of human malignancy. Maserang DL; Hyde RM; Dunn DJ South Med J; 1977 Feb; 70(2):222-8. PubMed ID: 65794 [No Abstract] [Full Text] [Related]
7. Tumor associated markers in clinical diagnosis. Rochman H Ann Clin Lab Sci; 1978; 8(3):167-75. PubMed ID: 77652 [No Abstract] [Full Text] [Related]
8. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen. Wagener C; Breuer H J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783 [No Abstract] [Full Text] [Related]
9. Editorial: When is a tumor marker not a tumor marker? Vaitukaitis JL N Engl J Med; 1975 Dec; 293(26):1370-1. PubMed ID: 52844 [No Abstract] [Full Text] [Related]
10. The immune system in gynecologic malignancies. Barber HR; Dorsett BH Mt Sinai J Med; 1980; 47(5):539-49. PubMed ID: 6969360 [No Abstract] [Full Text] [Related]
11. [Tumor markers in gynecologic malignancies]. Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic criteria for the tumor markers of the body fluids]. Konishi K; Nakagawa S; Watanabe K; Takamura S Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536 [No Abstract] [Full Text] [Related]
15. Monoclonal antibodies in the diagnosis and treatment of malignant conditions. Allum WH; Macdonald F; Fielding JW Surg Annu; 1986; 18():41-64. PubMed ID: 2417343 [No Abstract] [Full Text] [Related]
16. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV. Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449 [No Abstract] [Full Text] [Related]